Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis.
Wei R, Wu Y, Jiang S, Zhang A, Zhang L, Liu L, Wang Y, Zhang M, Mei H, Liu F, Xia L, Cui G, Fang J.
Wei R, et al. Among authors: zhang l, zhang m, zhang a.
Clin Exp Med. 2023 Dec;23(8):4609-4621. doi: 10.1007/s10238-023-01231-w. Epub 2023 Nov 4.
Clin Exp Med. 2023.
PMID: 37925380
Free PMC article.